SCHEMBL7002157

SCHEMBL7002157

COC(=O)c1nn(CC2CCC2)c(C(=O)OC)c1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
AR P10275 1/20 0.33
P2RY14 Q15391 1/20 0.33
LCK P06239 1/20 0.32
RET P07949 1/20 0.32
SRC P12931 1/20 0.32
CNR1 P21554 1/20 0.32
MAPK8 P45983 1/20 0.31
PTGER4 P35408 1/20 0.31
OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002165 0.93 P2RY14 (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL331277 0.82 CNR2 (0.37) ALDH1A1SMN1; SMN2MEN1KMT2ACNR1
SCHEMBL331632 0.82 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ACNR1
SCHEMBL7002038 0.81 LMNA (0.40) SMN1; SMN2LMNAP2RY14LCKRET
SCHEMBL8296901 0.76 KMT2A (0.42) ALDH1A1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL8295306 0.76 POLB (0.39) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL7002042 0.76 LMNA (0.39) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL8253700 0.76 MEN1 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ACNR1
SCHEMBL332202 0.75 MEN1 (0.33) ALDH1A1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL332338 0.74 PDE8B (0.41) ALDH1A1KMT2ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed
EP-1123296-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2001-08-16 EP disclosed
WO-2000024745-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 2000-05-04 WO disclosed